Profile data is unavailable for this security.
About the company
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
- Revenue in USD (TTM)193.58m
- Net income in USD-21.76m
- Incorporated2008
- Employees349.00
- LocationSI-BONE Inc471 El Camino Real, Suite 101SANTA CLARA 95050United StatesUSA
- Phone+1 (408) 207-0700
- Fax+1 (408) 557-8312
- Websitehttps://si-bone.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mesa Laboratories Inc | 247.54m | 3.73m | 500.49m | 730.00 | 140.00 | 2.68 | 17.41 | 2.02 | 0.6471 | 0.6471 | 44.81 | 33.79 | 0.5678 | 3.40 | 6.28 | 339,097.30 | 0.8564 | -8.81 | 1.13 | -9.71 | 62.40 | 61.98 | 1.51 | -25.15 | 1.45 | 1.62 | 0.4709 | -- | 11.47 | 15.41 | 99.22 | -- | 24.60 | 0.00 |
| Pacific Biosciences of California Inc | 160.01m | -546.38m | 516.26m | 575.00 | -- | 96.52 | -- | 3.23 | -1.84 | -1.84 | 0.5335 | 0.0177 | 0.1565 | 1.96 | 5.08 | -- | -53.45 | -22.47 | -59.23 | -24.40 | 33.97 | 33.11 | -341.47 | -214.45 | 2.44 | -19.72 | 0.9918 | -- | 3.89 | 15.19 | -76.34 | -- | -- | -- |
| Anteris Technologies Global Corp | 2.14m | -84.32m | 523.69m | 136.00 | -- | 55.68 | -- | 244.82 | -2.34 | -2.34 | 0.0594 | 0.1025 | 0.1065 | 1.53 | 11.88 | 15,728.75 | -420.16 | -- | -1,527.00 | -- | 67.94 | -- | -3,945.70 | -- | 0.8032 | -- | 0.046 | -- | -1.16 | -- | -65.77 | -- | -- | -- |
| Orthofix Medical Inc | 818.06m | -119.12m | 529.84m | 1.62k | -- | 1.19 | -- | 0.6477 | -3.04 | -3.04 | 20.82 | 11.20 | 0.9622 | 1.37 | 6.40 | 506,224.00 | -14.01 | -10.81 | -17.28 | -13.34 | 68.27 | 70.31 | -14.56 | -11.57 | 1.38 | -1.35 | 0.2837 | -- | 7.08 | 11.69 | 16.78 | -- | 8.75 | -- |
| Cytek Biosciences Inc | 196.83m | -12.82m | 542.15m | 692.00 | -- | 1.43 | -- | 2.75 | -0.1011 | -0.1011 | 1.54 | 2.96 | 0.3992 | 1.86 | 3.60 | 303,746.90 | -2.60 | 0.3407 | -3.02 | 0.3811 | 53.46 | 58.12 | -6.51 | 0.8678 | 4.48 | -- | 0.0213 | -- | 3.85 | 28.20 | 50.44 | -- | 30.83 | -- |
| Varex Imaging Corp | 854.40m | -67.70m | 566.49m | 2.40k | -- | 1.19 | -- | 0.663 | -1.63 | -1.63 | 19.34 | 11.38 | 0.7032 | 1.85 | 6.00 | 356,000.00 | -5.55 | -0.3327 | -6.45 | -0.3955 | 34.15 | 33.16 | -7.89 | -0.4661 | 1.87 | 2.22 | 0.4321 | -- | 4.14 | 2.73 | -47.38 | -- | -0.5159 | -- |
| Tactile Systems Technology Inc | 311.51m | 18.17m | 590.78m | 1.04k | 34.05 | 2.88 | 23.72 | 1.90 | 0.7768 | 0.7768 | 13.28 | 9.18 | 1.14 | 8.38 | 8.07 | 300,398.30 | 6.64 | 1.29 | 7.72 | 1.55 | 49.87 | 49.12 | 5.83 | 1.26 | 3.20 | -- | 0.00 | 0.00 | 6.76 | 9.11 | -40.52 | 9.10 | -15.97 | -- |
| Embecta Corp | 1.08bn | 139.50m | 602.27m | 1.85k | 4.30 | -- | 3.33 | 0.5578 | 2.37 | 2.37 | 18.31 | -10.35 | 0.9757 | 2.27 | 6.35 | 583,621.60 | 12.61 | 16.69 | 16.60 | 22.65 | 63.17 | 66.74 | 12.92 | 15.71 | 1.87 | 3.18 | 1.79 | 13.07 | -3.80 | -0.1033 | 21.84 | -25.93 | -26.03 | -- |
| Beta Bionics Inc | 88.57m | -77.84m | 613.70m | 404.00 | -- | 2.08 | -- | 6.93 | -2.07 | -2.07 | 2.21 | 6.70 | 0.4149 | 2.54 | 8.16 | 304,364.30 | -36.46 | -- | -40.57 | -- | 54.51 | -- | -87.89 | -- | 9.83 | -- | 0.00 | -- | 442.93 | -- | -24.17 | -- | -- | -- |
| Alpha Tau Medical Ltd | 0.00 | -39.97m | 614.75m | 125.00 | -- | 7.92 | -- | -- | -0.5212 | -0.5212 | 0.00 | 0.9099 | 0.00 | -- | -- | 0.00 | -40.90 | -34.28 | -44.43 | -36.47 | -- | -- | -- | -- | -- | -- | 0.0735 | -- | -- | -- | -8.89 | -- | 11.60 | -- |
| SI-Bone Inc | 193.58m | -21.76m | 665.19m | 349.00 | -- | 3.85 | -- | 3.44 | -0.5113 | -0.5113 | 4.55 | 3.98 | 0.8393 | 1.29 | 7.53 | 554,664.80 | -9.43 | -24.17 | -10.61 | -26.87 | 79.62 | 82.72 | -11.24 | -40.93 | 6.62 | -- | 0.1711 | -- | 20.37 | 19.96 | 28.67 | -- | 33.83 | -- |
| Bioventus Inc | 563.83m | 7.82m | 684.45m | 950.00 | 73.62 | 4.12 | 11.93 | 1.21 | 0.1123 | 0.1123 | 8.39 | 2.01 | 0.7666 | 1.95 | 4.47 | 606,267.80 | 1.31 | -6.29 | 1.89 | -8.49 | 67.76 | 67.40 | 1.71 | -12.07 | 1.14 | 1.73 | 0.616 | -- | 11.89 | 11.00 | 65.33 | -- | -15.55 | -- |
| Avanos Medical Inc | 699.90m | -468.60m | 691.64m | 2.23k | -- | 0.889 | -- | 0.9882 | -10.18 | -10.18 | 15.09 | 16.76 | 0.5139 | 2.14 | 5.76 | 314,279.30 | -34.41 | -4.82 | -39.66 | -5.42 | 52.28 | 54.01 | -66.95 | -11.32 | 1.36 | 8.92 | 0.1167 | -- | 2.15 | -0.2826 | -3,802.02 | -- | -18.86 | -- |
| CeriBell Inc | 82.81m | -52.46m | 733.38m | 281.00 | -- | 4.46 | -- | 8.86 | -1.45 | -1.45 | 2.29 | 4.43 | 0.6717 | 1.54 | 6.36 | 294,708.20 | -42.55 | -- | -48.06 | -- | 87.99 | -- | -63.35 | -- | 12.25 | -29.42 | 0.1074 | -- | 44.71 | -- | -37.30 | -- | -- | -- |
| Butterfly Network Inc | 88.45m | -79.87m | 767.91m | 190.00 | -- | 3.77 | -- | 8.68 | -0.3347 | -0.3347 | 0.3729 | 0.8071 | 0.3186 | 0.7409 | 3.93 | 465,515.80 | -28.77 | -- | -34.57 | -- | 43.24 | -- | -90.31 | -190.03 | 3.56 | -- | 0.00 | -- | 24.52 | -- | 45.78 | -- | -- | -- |
| STAAR Surgical Co | 230.59m | -96.37m | 800.85m | 1.16k | -- | 2.25 | -- | 3.47 | -1.96 | -1.96 | 4.64 | 7.17 | 0.464 | 1.29 | 2.80 | 199,300.80 | -19.39 | 3.81 | -22.26 | 4.42 | 73.87 | 77.03 | -41.79 | 5.42 | 4.35 | -- | 0.00 | 0.00 | -2.64 | 15.89 | -194.66 | -- | 18.11 | -- |
Data as of Feb 13 2026. Currency figures normalised to SI-BONE Inc's reporting currency: US Dollar USD
52.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| First Light Asset Management LLCas of 30 Nov 2025 | 5.15m | 11.86% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 2.93m | 6.76% |
| American Century Investment Management, Inc.as of 30 Sep 2025 | 2.84m | 6.54% |
| Brown Advisory LLCas of 30 Sep 2025 | 2.77m | 6.39% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 2.19m | 5.04% |
| Champlain Investment Partners LLCas of 30 Sep 2025 | 2.11m | 4.86% |
| Silvercrest Asset Management Group LLCas of 30 Sep 2025 | 1.46m | 3.37% |
| Impax Asset Management LLCas of 31 Dec 2025 | 1.20m | 2.77% |
| Point72 Asset Management LPas of 30 Sep 2025 | 1.09m | 2.51% |
| Granahan Investment Management, LLCas of 30 Sep 2025 | 1.04m | 2.40% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
